Like DMBA3-4 breast cancer cells, markedly fewer F4/80+ and CD11b+F4/80+ TAMs were present in LLC-DMBA compared with LLC-DMSO tumors (Figure 6, B–D). This evidence concerns the gene ITGAM and breast carcinoma.